Literature DB >> 17298299

Regulation and functional consequences of ADP receptor-mediated ERK2 activation in platelets.

Analia Garcia1, Haripriya Shankar, Swaminathan Murugappan, Soochong Kim, Satya P Kunapuli.   

Abstract

We have previously shown that ADP-induced thromboxane generation in platelets requires signalling events from the G(q)-coupled P2Y1 receptor (platelet ADP receptor coupled to stimulation of phospholipase C) and the G(i)-coupled P2Y12 receptor (platelet ADP receptor coupled to inhibition of adenylate cyclase) in addition to outside-in signalling. While it is also known that extracellular calcium negatively regulates ADP-induced thromboxane A2 generation, the underlying mechanism remains unclear. In the present study we sought to elucidate the signalling mechanisms and regulation by extracellular calcium of ADP-induced thromboxane A2 generation in platelets. ERK (extracllular-signal-regulated kinase) 2 activation occurred when outside-in signalling was blocked, indicating that it is a downstream event from the P2Y receptors. However, blockade of either P2Y1 or the P2Y12 receptors with corresponding antagonists completely abolished ERK phosphorylation, indicating that both P2Y receptors are required for ADP-induced ERK activation. Inhibitors of Src family kinases or the ERK upstream kinase MEK [MAPK (mitogen-activated protein kinase)/ERK kinase] abrogated ADP-induced ERK phosphorylation and thromboxane A2 generation. Finally ADP- or G(i)+G(z)-induced ERK phosphorylation was blocked in the presence of extracellular calcium. The present studies show that ERK2 is activated downstream of P2Y receptors through a complex mechanism involving Src kinases and this plays an important role in ADP-induced thromboxane A2 generation. We also conclude that extracellular calcium blocks ADP-induced thromboxane A2 generation through the inhibition of ERK activation.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17298299      PMCID: PMC1868805          DOI: 10.1042/BJ20061584

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  49 in total

1.  The P2Y1 receptor mediates ADP-induced p38 kinase-activating factor generation in human platelets.

Authors:  C Dangelmaier; J Jin; J L Daniel; J B Smith; S P Kunapuli
Journal:  Eur J Biochem       Date:  2000-04

Review 2.  The role of heterotrimeric G proteins in platelet activation.

Authors:  S Offermanns
Journal:  Biol Chem       Date:  2000 May-Jun       Impact factor: 3.915

3.  Role of the Src family kinase Lyn in TxA2 production, adenosine diphosphate secretion, Akt phosphorylation, and irreversible aggregation in platelets stimulated with gamma-thrombin.

Authors:  Moon J Cho; Tamara I Pestina; Shirley A Steward; Clifford A Lowell; Carl W Jackson; T Kent Gartner
Journal:  Blood       Date:  2002-04-01       Impact factor: 22.113

4.  Evidence for a role for phospholipase C, but not phospholipase A2, in platelet activation in response to low concentrations of collagen.

Authors:  L K Lockhart; C Pampolina; B R Nickolaychuk; A McNicol
Journal:  Thromb Haemost       Date:  2001-05       Impact factor: 5.249

5.  Loss of signaling through the G protein, Gz, results in abnormal platelet activation and altered responses to psychoactive drugs.

Authors:  J Yang; J Wu; M A Kowalska; A Dalvi; N Prevost; P J O'Brien; D Manning; M Poncz; I Lucki; J A Blendy; L F Brass
Journal:  Proc Natl Acad Sci U S A       Date:  2000-08-29       Impact factor: 11.205

6.  Protein kinase C alpha -mediated negative feedback regulation is responsible for the termination of insulin-like growth factor I-induced activation of nuclear phospholipase C beta1 in Swiss 3T3 cells.

Authors:  A Xu; Y Wang; L Y Xu; R S Gilmour
Journal:  J Biol Chem       Date:  2001-02-14       Impact factor: 5.157

Review 7.  Novel platelet inhibitors.

Authors:  J S Bennett
Journal:  Annu Rev Med       Date:  2001       Impact factor: 13.739

8.  Adenosine diphosphate (ADP)-induced thromboxane A(2) generation in human platelets requires coordinated signaling through integrin alpha(IIb)beta(3) and ADP receptors.

Authors:  Jianguo Jin; Todd M Quinton; Jin Zhang; Susan E Rittenhouse; Satya P Kunapuli
Journal:  Blood       Date:  2002-01-01       Impact factor: 22.113

9.  Genetic and pharmacological analyses of involvement of Src-family, Syk and Btk tyrosine kinases in platelet shape change. Src-kinases mediate integrin alphaIIb beta3 inside-out signalling during shape change.

Authors:  M Bauer; P Maschberger; L Quek; S J Briddon; D Dash; M Weiss; S P Watson; W Siess
Journal:  Thromb Haemost       Date:  2001-02       Impact factor: 5.249

10.  Regulation of RAS in human platelets. Evidence that activation of RAS is not sufficient to lead to ERK1-2 phosphorylation.

Authors:  David Tulasne; Teresa Bori; Steve P Watson
Journal:  Eur J Biochem       Date:  2002-03
View more
  38 in total

Review 1.  Interaction of P2 purinergic receptors with cellular macromolecules.

Authors:  Laszlo Köles; Zoltan Gerevich; João Felipe Oliveira; Zoltan Sandor Zadori; Kerstin Wirkner; Peter Illes
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2007-12-19       Impact factor: 3.000

2.  Contribution of the P2Y12 receptor-mediated pathway to platelet hyperreactivity in hypercholesterolemia.

Authors:  B Nagy; J Jin; B Ashby; M P Reilly; S P Kunapuli
Journal:  J Thromb Haemost       Date:  2011-04       Impact factor: 5.824

3.  Protein kinase C isoform ε negatively regulates ADP-induced calcium mobilization and thromboxane generation in platelets.

Authors:  Yamini S Bynagari-Settipalli; Parth Lakhani; Jianguo Jin; Kamala Bhavaraju; Mario C Rico; Soochong Kim; Donna Woulfe; Satya P Kunapuli
Journal:  Arterioscler Thromb Vasc Biol       Date:  2012-02-23       Impact factor: 8.311

Review 4.  P2Y12 receptor: platelet thrombus formation and medical interventions.

Authors:  Fatemeh Moheimani; Denise E Jackson
Journal:  Int J Hematol       Date:  2012-10-01       Impact factor: 2.490

5.  Potassium 2-(1-hydroxypentyl)-benzoate inhibits ADP-induced rat platelet aggregation through P2Y1-PLC signaling pathways.

Authors:  Hongyan Yang; Shaofeng Xu; Jiang Li; Ling Wang; Xiaoliang Wang
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2015-03-19       Impact factor: 3.000

6.  PDK1 governs thromboxane generation and thrombosis in platelets by regulating activation of Raf1 in the MAPK pathway.

Authors:  B K Manne; P Münzer; R Badolia; B Walker-Allgaier; R A Campbell; E Middleton; A S Weyrich; S P Kunapuli; O Borst; M T Rondina
Journal:  J Thromb Haemost       Date:  2018-05-08       Impact factor: 5.824

7.  Oxidized high-density lipoprotein inhibits platelet activation and aggregation via scavenger receptor BI.

Authors:  Manojkumar Valiyaveettil; Niladri Kar; Mohammad Z Ashraf; Tatiana V Byzova; Maria Febbraio; Eugene A Podrez
Journal:  Blood       Date:  2007-11-09       Impact factor: 22.113

8.  Two distinct roles of mitogen-activated protein kinases in platelets and a novel Rac1-MAPK-dependent integrin outside-in retractile signaling pathway.

Authors:  Panagiotis Flevaris; Zhenyu Li; Guoying Zhang; Yi Zheng; Junling Liu; Xiaoping Du
Journal:  Blood       Date:  2008-10-28       Impact factor: 22.113

9.  Mechanism of activation and functional role of protein kinase Ceta in human platelets.

Authors:  Yamini S Bynagari; Bela Nagy; Florin Tuluc; Kamala Bhavaraju; Soochong Kim; K Vinod Vijayan; Satya P Kunapuli
Journal:  J Biol Chem       Date:  2009-03-13       Impact factor: 5.157

10.  Raloxifene enhances spontaneous microaggregation of platelets through upregulation of p44/p42 MAP kinase: a case report.

Authors:  H Tokuda; A Harada; S Adachi; R Matsushima-Nishiwaki; H Natsume; C Minamitani; J Mizutani; T Otsuka; O Kozawa
Journal:  Osteoporos Int       Date:  2009-04-07       Impact factor: 4.507

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.